ANÁLISE COMPARATIVA DA PRODUÇÃO DE IMUNOTERAPIAS CAR PARA CÉLULAS T, NK E MACRÓFAGOS: UMA REVISÃO SISTEMÁTICA
Authors/Creators
Description
Esse trabalho foi apresentado em formato de Poster Eletrônico (E-Poster) no IV CONAEDUS - Congresso Nacional de Educação e Saúde (Edição 2025).
O presente trabalho foi apresentado pela pesquisadora Naiara Cristina de Souza Garajau nos dias 8, 9 e 10 de outubro de 2025 em ambiente online.
Segue o link para acesso do registro na plataforma ZENODO dos Anais do IV CONAEDUS: https://zenodo.org/records/18275830
PDF: https://editorahumanize.com/wp-content/uploads/2025/12/ANAIS-IV-CONAEDUS.pdf
Após o termino do evento, o trabalho foi publicado na plataforma Padlet, em seção criada pelo congresso sobre Temas Livre Apresentados, onde encontra-se no início da página, segue o link de acesso direto ao site está aqui: https://padlet.com/jtb2000abreu/conaedus-congresso-nacional-de-educa-o-e-sa-de-dcpppm7u5x57y6qd
Segue também o link de acesso direto ao documento em PDF via plataforma Padlet: https://padlet.com/jtb2000abreu/conaedus-congresso-nacional-de-educa-o-e-sa-de-dcpppm7u5x57y6qd/wish/wKmOZ5vEjL7PWzMA
- Currículo Lattes (Brazilian Academic Curriculum): http://lattes.cnpq.br/4285524447816279
- ORCID: https://orcid.org/0000-0002-8393-687X
- Contato via E-mail: leandro-maia-@hotmail.com
Files
[RESUMO EXPANDIDO] Produção Células CAR-T CAR-NK CAR-M.pdf
Additional details
Identifiers
- DOI
- 10.5281/zenodo.17841505
- ISBN
- 978-65--5255159-7
Related works
- Is supplemented by
- Book: 10.5281/zenodo.16993584 (DOI)
- Working paper: 10.33448/rsd-v14i9.49533 (DOI)
- Working paper: 10.33448/rsd-v14i8.49317 (DOI)
Dates
- Available
-
2025-10-10Trabalho Apresentado
- Available
-
2025-10-10Trabalho Disponível em Site do Congresso
Software
- Repository URL
- https://padlet.com/jtb2000abreu/conaedus-congresso-nacional-de-educa-o-e-sa-de-dcpppm7u5x57y6qd
- Programming language
- Python
- Development Status
- Active
References
- BEXTE, T. et al. Engineering of potent CAR NK cells using non-viral Sleeping Beauty transposition from minimalistic DNA vectors. Molecular therapy: the journal of the American Society of Gene Therapy, v. 32, n. 7, p. 2357–2372, 2024.
- CAMPBELL, M. et al. Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline. BMJ, 2020.
- DAHER, M. et al. CAR-NK cells: the next wave of cellular therapy for cancer. Clinical & translational immunology, v. 10, n. 4, p. e1274, 2021.
- DEPIL, S. et al. "Off-the-shelf" allogeneic CAR T cells: development and challenges. Nature reviews. Drug discovery, v. 19, n. 3, p. 185–199, 2020.
- ERIKSEN, M. B.; FRANDSEN, T. F. The impact of the PICO format on literature search result in systematic reviews. Journal of the Medical Library Association, 2018.
- HOSSEINI, M. et al. PICO format for formulating research questions in systematic reviews. World Journal of Methodology, 2024.
- REISS, K. A. et al. CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trial. Nature medicine, v. 31, n. 4, p. 1171–1182, 2025.
- LI, Y. et al. Human iPSC-derived natural killer cells engineered with chimeric antigen receptors enhance anti-tumor activity. Cell stem cell, v. 23, n. 2, p. 181- 192.e5, 2018.
- LIU, E. et al. Use of CAR-transduced natural killer cells in CD19-positive lymphoid tumors. The New England journal of medicine, v. 382, n. 6, p. 545–553, 2020.
- MORRIS, E. C. et al. Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy. Nature reviews. Immunology, v. 22, n. 2, p. 85–96, 2022.
- NEELAPU, S. S. et al. Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma. The New England journal of medicine, v. 377, n. 26, p. 2531–2544, 2017.
- PAGE, M. J. et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ, 2021.
- LU, J. et al. CAR Macrophages: a promising novel immunotherapy for solid tumors and beyond. Biomarker research, v. 12, n. 1, p. 86, 2024.
- KAWAMOTO, H.; MASUDA, K. Trends in cell medicine: from autologous cells to allogeneic universal-use cells for adoptive T-cell therapies. International immunology, v. 36, n. 2, p. 65–73, 2024.